Since the discovery of -glucosidase inhibitors and their inhibitory effects on the digestion of carbohydrates, promising results have been obtained as to the antidiabetic effects of this family of compounds. Antiangiogenic compounds have been identified that suppress tumor growth via a unique mechanism, confirming that such compounds can act as clinically applicable anticancer agents. Lipid peroxidation and lipid glycation have been suggested to play roles in food deterioration and in the pathophysiology of human diseases such as atherogenesis and diabetes, and antioxidative and antiglycative compounds can potentially be used in the prevention of food deterioration as well as to treat disease. On this basis, this review describes studies of -glucosidase inhibition by mulberry 1-deoxynojirimycin, antiangiogenic effects of rice bran tocotrienol, and membrane lipid peroxidation/glycation and its inhibitors. These studies are ongoing in our work, with an emphasis on analytical techniques.
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Key words: 1-deoxynojirimycin; tocotrienol; lipid hydroperoxide; lipid glycation; analytical technique I. 1-Deoxynojirimycin 1. Quantitative analysis of the -glucosidase inhibitor mulberry 1-deoxynojirimycin 1-Deoxynojirimycin (DNJ) is a naturally-occurring alkaloid with promising physiological activity in vivo, including inhibition of intestinal -glucosidase. 1) It is a D-glucose analog, in which the oxygen in the pyranose ring is replaced by nitrogen ( Fig. 1A) . In 1976, DNJ was isolated from the mulberry tree (Morus alba) and identified for the first time. 2) Isolation of DNJ led to speculation that dietary mulberry DNJ might be beneficial in delaying carbohydrate digestion by competitive -glucosidase inhibition, thereby suppressing abnormally high blood glucose levels and helping to prevent diabetes.
Various mulberry products (teas, powders, and tablets) are commercially available in Japan and many other countries. These advertise the bioavailability of DNJ, but their DNJ content has not been specified, mainly due to lack of a method to measure DNJ. Hence, we developed several methods of determining DNJ content by hydrophilic interaction chromatography (HILIC)-evaporative light scattering detection, HILICmass spectrometry (MS), and HILIC-tandem mass spectrometry (MS/MS) ( Fig. 1A) . [3] [4] [5] [6] By these methods, it was confirmed that DNJ content in mulberry products is relatively low, approximately 0.1% (100 mg/100 g dry product), and that some products contain only trace amounts of DNJ. 3, 7) Thus, if DNJ-enriched products can be produced, its pharmacological administration offers a potential therapeutic approach to diabetes prevention.
To develop DNJ-enriched products, DNJ concentrations in mulberry leaves obtained from different cultivars, harvest seasons, and harvest regions were determined and compared by the methods described above (Fig. 1B) , and mulberry leaves containing higher levels of DNJ were selected. Young mulberry leaves from the tops of branches were found to contain relatively high amounts of DNJ. After optimization of the mulberry leaf harvesting, drying, and extraction processes, we produced food-grade mulberry powder enriched with DNJ (approximately 1.0%). [7] [8] [9] Studies in human subjects indicated that this DNJ-enriched powder lowered blood sugar levels (Fig. 1C ). 8, 10) No adverse events occurred during the human studies. 8, 10, 11) Therefore, this DNJenriched product may represent a therapy for oral treatment of non-insulin-dependent diabetes mellitus (type 2 diabetes). This possibility is now under investigation by our group in clinical studies in order to obtain ''Food for Specified Health Use (FOSHU)'' status in Japan.
A novel gelatin crosslinking method retarded the release of mulberry DNJ, providing a prolonged hypoglycemic effect
As described above, mulberry DNJ has therapeutic potency in the suppression of postprandial blood glucose levels, thereby possibly preventing or serving to treat diabetes mellitus, but DNJ has a relatively short half-life in vivo (approximately 2 h). 4) Therefore, several doses of mulberry DNJ are required to achieve optimal therapeutic results. We aimed to delay the release of mulberry DNJ using biodegradable matrices to maintain intestinal DNJ concentrations and prolong the hypoglycemic effect in vivo. 12) A novel gelatin crosslinking method was adopted to develop DNJ-entrapped microspheres (DNJ-MSs). A higher extent of crosslinking and larger DNJ-MSs decreased the rate of mulberry DNJ release in vitro. An in vivo rat study indicated that DNJ-MS can suppress postprandial blood glucose levels after sucrose administration at the initial as well as 3 h time point. In contrast, MSs without DNJ did not suppress postprandial blood glucose levels at 3 h. These results suggest that mulberry DNJ in the form of DNJ-MS can afford a prolonged hypoglycemic effect by sustaining DNJ release.
Evaluation of other physiological functions of DNJ in a study of rats
The -glucosidase inhibitory activity of DNJ is of interest, but its other physiological functions have not been widely investigated. Hence, our research group examined other effects of DNJ in a study of rats, and found that dietary DNJ supplementation enhanced expression of adiponectin mRNA in white adipose tissue, increased plasma adiponectin levels, enhanced expression of AMPK mRNA, activated the -oxidation system, and suppressed lipid accumulation in the liver. 13) Intake of DNJ did not cause hepatic dysfunction, and led to reduced oxidative stress. Thus, DNJ might be therapeutically useful and safe in the treatment of obesity as well as diabetes. Further studies are needed to evaluate these effects, mechanism, and safety of DNJ in animal disease models and human studies.
Microbial mass production of DNJ for therapeutic applications
DNJ has long been thought to be produced by several strains of Bacillus and Streptomyces spp. 14) To date, DNJ for therapeutic purposes has been extracted in limited amounts exclusively from mulberry leaves, but certain microorganisms may be more suitable for largescale production of DNJ. Using HILIC-MS/MS, we obtained evidence of DNJ production in Bacillus subtilis DSM704. 15) In addition, we conducted a screening of 750 microorganisms, and identified Bacillus strains (Bacillus amyloliquefaciens AS385 and Bacillus subtilis B4) that produce DNJ in large quantities ( Fig. 1D ). An investigation of the effects of various culture conditions, using Bacillus subtilis DSM704 and the DNJ highproduction Bacillus strains, yielded evidence that sorbitol supplementation increases yield of DNJ precursor 2-amino-2-deoxy-D-mannitol, thereby increasing DNJ production. The role of sorbitol in increased DNJ production was confirmed by an observed increase in mRNA expression of the gene gabT1, one of three important genes that form part of DNJ biosynthetic gene cluster. When Bacillus amyloliquefaciens AS385 was cultured in medium supplemented with sorbitol, extracellular DNJ concentration reached a maximum of 460 mg/L of medium, indicating that it can serve as a source of DNJ for food-and drug-grade products. These findings not only led to greater understanding of the DNJ biosynthetic pathway, but also suggested a method of microbial mass production of DNJ for therapeutic applications. 
II. Tocotrienol

Antiangiogenic effects of unsaturated vitamin E, tocotrienol
Angiogenesis is a complex process by which new capillaries sprout from pre-existing blood vessels. It plays a crucial role in many pathological conditions, including tumor growth. 16) Once a tumor becomes vascularized, the tumor mass can expand rapidly. These newly formed vessels promote tumor growth and can cause tumor cells to become more malignant and metastatic. Hence, angiogenesis has become a therapeutic target in cancer, and a wide variety of therapies directed at interfering with this process are now under development. 17) In 1922, tocopherol (Toc), found in green leafy vegetables, was discovered to be a micronutrient essential for reproduction. 18) More than 40 years later, tocotrienol (T3, Fig. 2A ) was isolated from latex. 19) Structurally, these vitamin E compounds differ only in their side chains. Toc is present in a wide variety of foods such as vegetable oils and nuts, but fewer foods contain T3. Rice bran, palm oil, and annatto seed are rich in T3. 20) To date, eight forms of vitamin E (-, -, -, and -Toc and -, -, -, and -T3) have been found in nature. All forms can induce antioxidative radical scavenging effects, and in some model membrane studies, T3 has been found to be a more potent antioxidant than Toc. 21) Moreover, T3 has recently gained increasing interest due to several biological activities (e.g., lowering cholesterol and anti-cancer effects) that appear to differ somewhat from those of Toc. 22) On this basis, we carried out a series of investigations to test the hypothesis that T3 can suppress cancer through its inhibitory effect on tumor angiogenesis ( Fig. 2A ). [23] [24] [25] [26] [27] 2. In vitro study of angiogenesis inhibition by T3 Several growth factors have major roles in neovascularization, and one of the most important of these is vascular endothelial growth factor (VEGF). 28) Hence, we examined the effects of T3 on VEGF-induced angiogenic processes (proliferation, migration, and tube formation) in human umbilical vein endothelial cells (HUVECs). 29) T3 inhibited HUVEC proliferation, with inhibitory potency as follows: -T3 > -T3 > -T3 > -T3. Better incorporation of -T3 into HUVECs may be the reason for its greater inhibitory effect on proliferation. -T3 also suppressed migration and tube formation in HUVECs, and the amount of -T3 required to inhibit cell migration or tube formation was lower than that required to attenuate cell proliferation. These findings suggest that the main antiangiogenic effects of -T3 are the suppression of migration and tube formation in HUVECs.
Molecular mechanism of angiogenesis inhibition by T3
Increased angiogenesis in response to hypoxia is part of an adaptive response mediated by transcription factor hypoxia-inducible factor (HIF)-1. 30) HIF-1 activates expression of the VEGF gene by binding to a hypoxia response element (HRE) in the VEGF promoter region.
HIF-1 expression is elevated in many human cancers, confirming that the hypoxia/HIF-1 system is a potential molecular target for cancer therapeutics. 31) Hence, we examined the effects of T3 on mRNA expression of HIF-1 and VEGF in human colon cancer cell line DLD-1. 32) DLD-1 cells incubated under hypoxic conditions showed greater VEGF mRNA expression than normoxic cultures. -T3 suppressed hypoxia-induced VEGF mRNA expression. Combined hypoxia and -T3 treatment reduced HIF-1 mRNA expression. Then we measured expression of HIF-1 protein and performed transient transfection of DLD-1 cells with luciferaseplasmid constructs containing an HRE. Western blotting revealed that hypoxia markedly increased HIF-1 protein levels, whereas -T3 reduced hypoxia-induced HIF-1 protein accumulation. Hypoxia elicited an increase in luciferase activity as determined using an HRE-luciferase reporter construct, and transcriptional activity was inhibited by -T3.
VEGF receptor (VEGFR)-2 is the main receptor for mediating the pro-angiogenic effects of VEGF in tumorassociated endothelium. 33) VEGFR-2 activates multiple downstream signaling cascades, including the PI3K/ PDK/Akt pathway. Hence, we investigated to determine whether the antiangiogenic effects of T3 are mediated by modulation of these pathways. 34) Stimulation of HUVECs with tumor-cell-cultured medium (CM) containing angiogenic growth factors was accompanied by increased phosphorylation of VEGFR-2 and the PI3K/ PDK/Akt pathway proteins (PDK and Akt). When -T3 was added to CM, we found that VEGFR-2 and PI3K/ PDK/Akt pathway protein phosphorylation were suppressed. High-dose treatment with T3 blocked Akt, inhibited downstream survival signals, and enhanced the ASK-1 and p38 pathway, thereby eliciting an apoptotic effect in endothelial cells.
Considering the above results, the following mechanism might be responsible for the antiangiogenic effect of T3: In tumor cells, T3 inhibits hypoxia-induced HIF-1 protein accumulation, leading to reduced VEGF mRNA expression. Moreover, in endothelial cells, T3 downregulates VEGFR-2 and the PI3K/PDK/Akt signaling pathway, thereby inhibiting cell survival and tube formation, resulting in inhibition of angiogenesis ( Fig. 2B ).
In vivo study of angiogenesis inhibition by T3
To evaluate the effects of T3 on in vivo tumor angiogenesis, we conducted a Matrigel plug assay using nude mice, 34) because numerous studies have reported the ability of this assay to assess in vivo efficacy of inhibitors of tumor-associated angiogenesis. 35) DLD-1-Matrigel-implanted control mice appeared to show significant neovascularization as compared to mice injected with Matrigel alone. Suppression of vessel formation was clearly observed in mice implanted with DLD-1-Matrigel containing -T3. Histological analysis of the DLD-1-Matrigel plugs of control mice indicated an obvious angiogenic response. CD31/platelet endothelial cell adhesion molecule-1 (PECAM-1)-positive endothelial cells and red blood cells (RBCs) stained with hematoxylin and eosin were clearly present, indicating that endothelial cells had infiltrated the DLD-1-Matrigel. In contrast, implantation with DLD-1-Matrigel contain-ing -T3 resulted in low numbers of both CD31/ PECAM-1-positive and erythroid cells, suggesting that -T3 inhibited endothelial cell invasion and new vessel formation. These results might have been due to the inhibitory effects of -T3 on endothelial signaling induced by pro-angiogenic factors such as VEGF.
Evaluation of other physiological functions of T3
We also investigated other biological activities of T3, and have found that T3 acts as a potent regulator of telomerase, confirming the anti-proliferative function of T3. 36) In the cell culture study described above, 32) we found that the inhibitory effects of T3 on tumor angiogenesis were mediated in part via reduction of cyclooxygenase 2 (COX-2) and interleukin (IL). It is well known that these molecules act not only as angiogenic factors but also as inducers of inflammation. We therefore investigated the effects of T3 on skin inflammation in vitro and in vivo, and found that T3 showed potent anti-inflammatory action mediated by downregulation of COX-2 and IL. 37) In another study, we found that T3 attenuated triglyceride (TG) accumulation in HepG2 cells and in F344 rats. 38) Hence, the lipid-lowering effects of dietary T3 might be mediated in part by a reduction in TG synthesis. Supplementation with T3 for 13 weeks in Fischer 344/slc rats showed a safety profile with no side effects. 39) These possible effects and safety of T3 should be investigated further with a view to human application.
Developing a rice variety rich in T3 for nutraceutical purposes
As described above, rice bran contains functional compounds, including T3. 20) T3 has received considerable attention for its various biological properties. 22) It shows greater antioxidative, antihypercholesterolemic, anticancer, and neuroprotective activity than Toc. In addition, we have found that T3 suppresses pathological angiogenesis, an important stage in the progression of several diseases, including cancer. 26, 27, 34) These findings suggest that T3 has a wide range of physiological functions, and the development of a rice variety that can biosynthesize high concentrations of T3 is desirable for nutraceutical application. Hence, we developed a rapid screening method for T3-rich rice bran by one-step equilibrium direct solvent extraction followed by normal-phase high-performance liquid chromatography (HPLC), and determined the T3 content in 250 varieties of rice (Fig. 2C ). 40) Subsequently we crossed T3-rich varieties such as Milyang23 with Koshihikari, the most popular rice variety in Japan (Fig. 2D) , resulting in more self-pollinated progeny with significantly higher T3 levels. 41) These newly-produced T3 rich varieties might be useful for nutraceutical applications. In addition, QTL analysis revealed five putative QTLs corresponding to T3 biosynthesis, providing new insight into genetic regulation of the activity of enzymes involved in T3 production in rice.
III. Lipid Peroxidation
Importance of evaluation of lipid peroxidation in food and biological samples
Peroxidative stress on lipid molecules not only diminishes the nutritive value of foods, but plays a role in several biochemical processes, including aging and disease pathophysiology. 42, 43) Hence, it is important to measure lipid hydroperoxides as a primary oxidation product in order to determine the degree of lipid oxidization in foods and in biomembranes of the body, and also to maintain health and the wholesome character of foods.
In 1987, Miyazawa et al. established a new methodology termed chemiluminescence detection (CL)-HPLC, which is sensitive and selective enough to measure lipidclass hydroperoxide levels in foods and in biological samples such as blood plasma and tissues. [44] [45] [46] A unique post-column chemiluminescence reagent consisting of cytochrome c and luminol in an alkaline borate-buffered solution is utilized for CL-HPLC. 47) By CL-HPLC, formation of mono-, bis-, and tris-hydroperoxides was confirmed to occur at the initial stage of triacylglycerol oxidation in food oils. 48) Animal studies have shown that long-term fish oil consumption creates a high risk of membrane phospholipid peroxidation (an abnormal accumulation of phosphatidylcholine hydroperoxide, PCOOH, Fig. 3A) together with an increased need for -Toc as a membrane antioxidant. 49) Membrane phospholipid peroxidation (PCOOH accumulation) increases with age (senescence). 50) These findings strongly sug-gest the importance of determining lipid peroxidation levels in food and biological systems.
In measuring lipid hydroperoxides by CL-HPLC or other HPLC techniques, researchers are faced with the problem of finding suitably pure hydroperoxide standards. Lipid hydroperoxides prepared from photo-or free radical-oxidized lipids are generally used as standard compounds, but the purity of the hydroperoxides in such standards is not always high. Impurities in the standard can be attributed to a number of analytical errors. Over 50 years ago, it was reported that under acidic condition, some vinyl ethers can react with organic hydroperoxides to form perketals. 51, 52) Hence, we predicted that this reaction can be applied to the preparation of pure lipid hydroperoxides, and this was achieved using a vinylether molecule (2-methoxypropene, MxP) ( Fig. 3B ). 53) The procedures include protecting the hydroperoxide group as a perketal using MxP. The perketal was separated by HPLC, and then the pure hydroperoxide was regenerated from the perketal. The resulting lipid hydroperoxide (e.g., PCOOH) had high purity (>95%). This pure stable PCOOH was appropriate for use as a standard for determination studies. Hence, we are currently using this PCOOH standard, CL-HPLC device, as well as a newly developed HPLC-MS(/MS) system for quantification of lipid hydroperoxides in clinical samples (see 2 and 4). Pure PCOOH was also used in cell culture studies to evaluate PCOOH pathogenicity (see 3).
RBC lipid peroxidation may be involved in the pathogenesis of Alzheimer's disease: possible therapeutic effects of xanthophylls
Alzheimer's disease (AD) is the most common form of dementia. Since it is associated with a progressive accumulation of amyloid -peptide (A) in the human brain, the pathogenic role of A in the brain is widely recognized. 54) In addition to its effects on the brain, A is also present in blood circulation, and several oxidative alterations have been observed in the blood of dementia patients. For example, irregular distortions and rapid aging of RBCs are found in them. We analyzed RBCs of AD patients by CL-HPLC and the pure lipid hydroperoxide standard described above, and found that there was an abnormal accumulation of phospholipid hydroperoxides (PLOOH), including PCOOH and phosphatidylethanolamine hydroperoxide (PEOOH), in the RBCs of AD patients (Fig. 3C ). 55) This study was performed in collaboration with the Department of Geriatrics and Gerontology, Institute of Development, Aging and Cancer of Tohoku University, Sendai, Japan. Our group and other researchers have further investigated these mechanisms, and found that A induces oxidative injury in RBCs by binding to them and causing RBC phospholipid peroxidation (Fig. 3D ). 56, 57) A can also induce binding of RBCs to endothelial cells and decrease endothelial viability, perhaps through the generation of oxidative and inflammatory stress. 58) These studies [56] [57] [58] suggest that A plays a key role in blood and impairs RBC function (e.g., oxygen delivery to the brain) through oxidative damage, thereby potentially contributing to the pathogenesis of AD. In accord with this hypothesis, we found recently evidence that A is indeed present in human RBCs. 59) Based on these findings, we are currently collecting blood samples from living AD subjects to investigate further the oxidative and pathogenic roles of RBC A and the suitability of RBC A as a biomarker for AD.
On the other hand, it is well recognized that one of the major physiological activities of carotenoids is their antioxidant action and their protective effect against lipid peroxidation in biological membranes. Xanthophylls have recently garnered increasing scientific interest due to their antioxidative, antiobesity, and antiinflammatory activity, all of which differ somewhat from those of nonpolar carotenoids. 60) As explained above, we found greater accumulations of PLOOH in the RBCs of AD patients. As to the concentrations of RBC carotenoids, xanthophylls, especially lutein, in AD patients were significantly lower than in control subjects. 55, 61) An inverse relationship was found between RBC carotenoids, especially lutein, and PLOOH concentrations in AD patients (Fig. 3C ). In addition, in vitro and in vivo studies in mice and humans have indicated that xanthophylls (lutein and astaxanthin) can effectively inhibit accumulation of RBC PLOOH. 56, 59, 62, 63) For instance, an in vitro study showed that A-induced RBC damage was attenuated by treatment of RBCs with xanthophylls. 56) A human study showed that xanthophyll (astaxanthin) supplementation decreased RBC A as well as PLOOH. 59) On the basis of these evidences, it appears that carotenoids, especially xanthophylls, act as important antioxidants in RBCs and thereby may contribute to prevention of AD. This warrants their testing in other models of AD with a realistic prospect of use in human therapy.
Biological roles of PCOOH in atherogenesis: PCOOH pathogenicity may be reduced via the use of food constituents
Oxidative lipid modifications also play an important role in the pathogenesis of atherosclerosis. 42) Among oxidatively modified lipids, PCOOH, a primary oxidation product of phosphatidylcholine (PC), was observed to accumulate in arterial walls and blood plasma in atherosclerotic rabbits. 64) PCOOH has also been detected in human atherosclerotic lesions. 65, 66) Furthermore, PCOOH accumulation in plasma has been shown in human subjects with pathological conditions such as hyperlipidemia and diabetes. [67] [68] [69] Because hyperlipidemia and diabetes are strongly associated with an increased incidence of atherosclerosis, higher levels of plasma PCOOH in these patients may be involved in atherogenesis, but the biological role of PCOOH in atherogenesis has not been definitively established.
To investigate the atherogenicity of PCOOH, we prepared pure PCOOH (1-palmitoyl-2-hydroperoxyoctadecadienoyl-sn-glycero-3-phosphocholine), 53) and evaluated the effects of PCOOH on THP-1 monocytic cell adherence to immobilized vascular endothelial cell adhesion molecules. 70) This study was performed in collaboration with the Department of Medicine, Division of Endocrinology and Metabolism, Nippon Medical School, Tokyo. We found that THP-1 cell adhesion to intracellular adhesion molecule-1 (ICAM-1) was dosedependently increased by addition of PCOOH. In contrast, non-oxidized PC did not affect adhesion. In PCOOH-treated cells, obvious protruding F-actin-rich membrane structures were formed, and lymphocyte function-associated antigen-1 (LFA-1) was localized to the protruding structures. Cytochalasin D, an actin polymerization inhibitor, suppressed PCOOH-induced cell adhesion to ICAM-1 and the membrane protrusions. These results indicate that PCOOH evokes LFA-1mediated cell adhesion to ICAM-1 via actin cytoskeletal organization. This mechanism might participate in monocyte adherence to the arterial wall in the initiation of atherosclerosis.
Recently, our research group investigated further the mechanism of PCOOH-induced THP-1 cell adhesion to ICAM-1. 71) Isoprenoid depletion by fluvastatin and geranylgeranyltransferase inhibition by GGTI-286 suppressed PCOOH-induced cell adhesion to ICAM-1 and F-actin-rich membrane protrusion formation. Pull-down assays demonstrated activation of Rac1 and Rac2 in PCOOH-treated cells. Pan-Rho-family GTPase inhibitor Clostridium difficile toxin B, Rac-specific inhibitor NSC23776, and RNA interference against Rac isoforms all suppressed cell adhesion. These findings indicate the involvement of Rac GTPase activation in PCOOHinduced cell adhesion to ICAM-1 via actin reorganization.
Oxidized low density lipoprotein (Ox-LDL) is now recognized as a causative factor for atherosclerosis. 72) A large number of studies have found apoptotic and cytotoxic effects of Ox-LDL on endothelial cells, smooth muscle cells, and monocytes/macrophages, suggesting that Ox-LDL plays a role in the promotion of atherosclerosis. Recently it was reported that Ox-LDL can induce endothelial angiogenesis, including capillary tube formation. 73) Thus, in addition to its apoptotic and cytotoxic effects, Ox-LDL-induced angiogenesis also contributes to the progression of atherosclerosis and to plaque instability. Since Ox-LDL contains PCOOH, we investigated to determine whether PCOOH would stimulate angiogenic responses (VEGF-induced cell proliferation, migration, and tube formation, and angiogenesis-related gene/protein expression) in HUVECs. 74) VEGF induced proliferation, migration, and tube formation in HUVECs, and these angiogenic responses were all enhanced by PCOOH, but not by native (nonoxidized) PC. The angiogenic effects of PCOOH are thought to be mediated via generation of reactive oxygen species (ROS) and activation of the PI3K/ AKT and MAPK pathways. We also confirmed the angiogenic activity of PCOOH in a rat aortic ring assay. These results indicate that PCOOH can elicit several angiogenic responses, and these findings should enhance our fundamental understanding of the involvement of PCOOH and Ox-LDL in the development of atherosclerosis through plaque angiogenesis.
We have found that PCOOH has both atherogenic and angiogenic activity. It has also been reported to decrease the viability of neuronal PC-12 cells by attacking microtubule systems, suggesting that PCOOH involves in the pathogenesis of neural disease. 75) Further studies are required to determine the other biological functions of PCOOH. On the other hand, as a preventive strategy, catechin supplementation has been shown to increase antioxidant capacity and to prevent plasma phospholipid peroxidation in humans, [76] [77] [78] and thus the pathogenicity of PCOOH may be reduced by catechin consumption in tea.
The role of lipid peroxidation in liver and skin damage
The mechanism of hepatocarcinogenesis in hepatitis C virus (HCV) infection remains undetermined. One possibility is the involvement of oxidative stress, which can produce genetic mutations as well as gross chromosomal alterations and contribute to cancer development. We collaborated with the Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, and showed that the core protein of HCV induces liver lipid peroxidation and hepatocellular carcinoma in transgenic mice, indicating that oxidative stress (lipid peroxidation) and HCV involve in hepatocarcinogenesis. 79) We have also investigated skin squalene (SQ) as a possible principal lipid target of oxidative stress (e.g., sunlight exposure). 80) Due to its six double bonds, SQ peroxidation can yield various positional hydroperoxide isomers. We prepared pure squalene hydroperoxide (SQOOH) isomers and developed methods of analyzing them by HPLC-MS/MS. 81) We found that the total concentration of SQOOH isomers in forehead skin was markedly increased, by up to 3-fold, after 3 h of sunlight exposure. As increasing evidence of skin SQOOH content has emerged, it has been implicated in the pathogenesis of skin alterations including sunburn and acne. 82) Hence, we investigated to determine whether SQOOH would induce inflammatory responses in immortalized human keratinocyte cell line HaCaT, and found that it caused increases in the expression of inflammatory genes such as ILs as well as COX-2. 83) In accord with the upregulation of COX-2 mRNA, SQOOH enhanced ROS generation, nuclear factor kappa B activation, COX-2 protein expression, and prostaglandin E2 production. These results, showing that SQOOH induces inflammatory responses in HaCaT, suggest that it plays an important role in inflammatory skin disorders.
IV. Lipid Glycation
Analysis of lipid glycation products in blood and tissues of diabetic patients and animals
We have established methods to measure lipid hydroperoxides as primary oxidation products, by CL-HPLC and HPLC-MS(/MS), as described above. By these methods, our group confirmed that plasma PCOOH is abnormally high in diabetic patients. 69) Based on these results, we hypothesized that PCOOH-mediated cytotoxity is involved in the pathophysiology of the disease.
In the investigation to determine why PCOOH increases in diabetic plasma, we found that blood and tissues of diabetic patients and animals contained an abnormally high level of glycated lipids. The glycated lipid was identified as an Amadori product of phosphatidylethanolamine (deoxy-D-fructosyl phosphatidylethanolamine, Amadori-PE, Fig. 4A, B ) by HPLC-MS (/MS). [84] [85] [86] Amadori-PE generates ROS and thus triggers lipid peroxidation. 84) It is therefore likely that phosphatidylethanolamine (PE) is exposed to glycation under hyperglycemic conditions, yielding Amadori-PE in vivo. Amadori-PE causes oxidative stress (e.g., PCOOH formation), leading to disorders of cellular integrity such as stimulation of angiogenesis and induction of telomerase activity (Fig. 4C ). 87, 88) Amadori-PE and PCOOH might therefore play roles in the development of diabetes. Besides Amadori-PE, we found recently that advanced glycation end products of PE are also present in human blood. 89, 90) In addition, lipid glycation impairs the flavor, color, and nutritive value of foods containing large amounts of Amadori-PE, which include infant formula and chocolate. 91) 
A role of pyridoxal 5 0 -phosphate as lipid glycation inhibitor
Despite the potential significance of Amadori-PE in pathological signaling and food deterioration, no lipid glycation inhibitors have been identified. This is due to lack of a lipid glycation model for inhibitor screening. Hence, we optimized and developed such a lipid glycation model. 92, 93) Using this model, various protein glycation inhibitors, antioxidants, and food compounds were evaluated for their anti-glycative abilities. Pyridoxal phosphate (PLP) and pyridoxal (vitamin B6 derivatives) were found to be the most effective antiglycative compounds. They were easily condensed with PE before glucose/PE reaction. Since dietary supplementation with PLP decreased plasma Amadori-PE concentration in streptozotocin-induced diabetic rats (Fig. 4D) , it is likely that PLP acts as a lipid glycation inhibitor in vivo, and hence might contribute to diabetes prevention. Further investigation is necessary to determine the effects of lipid glycation inhibitors such as PLP on lipid glycation, lipid peroxidation (e.g., PCOOH formation), oxidative stress, pathophysiology of human disease, and food deterioration.
V. Conclusion
-Glucosidase inhibition by mulberry DNJ, antiangiogenic effects of rice bran T3, and membrane lipid peroxidation/glycation and inhibition of it are active areas of research in our laboratory, with an emphasis on analytical techniques. We have discovered novel molecules and functions of food and nutrients, and have developed new foods and other products that may help to prevent of food deterioration and to treat disease.
